Literature DB >> 3125631

Characterization of the biological and immunological properties of fractions of prairie rattlesnake (Crotalus viridis viridis) venom.

C L Ownby1, T R Colberg.   

Abstract

Prairie rattlesnake (Crotalus viridis viridis) venom was separated using liquid column chromatography. The fractions were tested for biological activity in mice and for immunological reactivity against polyvalent (Crotalidae) antivenom and a monovalent antivenom to the crude venom. Several of the basic fractions and most of the non-basic fractions had hemorrhagic activity. Six of eight basic fractions had direct myotoxic activity, two of the basic fractions. Monovalent antivenom formed multiple precipitin bands with almost all of the fractions. These results clearly demonstrate that most of the venom components are antigenic and immunogenic. Immunodiffusion using the monovalent antivenom demonstrated that C. v. viridis venom contains many antigens common to 10 other crotaline venoms. One of the hemorrhagic components was present in five of the other venoms tested, one of the direct myotoxic components was present in three other venoms, and one of the lethal components was common to two other venoms. Another highly active hemorrhagic component was common to all of the venoms tested except that of Trimeresurus flavoviridis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3125631     DOI: 10.1016/0041-0101(87)90011-0

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  2 in total

1.  The effect of the desert cobra (Walterinnesia aegyptia) crude venom and its protein fractions on the metabolic activity of cultured human fibroblasts.

Authors:  S S al-Saleh
Journal:  Cell Biol Toxicol       Date:  1996-06       Impact factor: 6.691

2.  The effect of Walterinnesia aegyptia venom proteins on TCA cycle activity and mitochondrial NAD(+)-redox state in cultured human fibroblasts.

Authors:  Hazem K Ghneim; Yazeed A Al-Sheikh; Mourad A M Aboul-Soud
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.